http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
손일웅 ( Il Woong Sohn ),방소영 ( So Young Bang ),김담 ( Dam Kim ),김태환 ( Tae Hwan Kim ) 대한류마티스학회 2010 대한류마티스학회지 Vol.17 No.1
Back pain is the most common symptom of ankylosing spondylitis (AS). The aggravation of back pain in AS patients is usually thought to be a flare-up of the disease activity. We report here on the case of a 31-year-old AS patient with low back pain. The lesions of this patient were unexpectedly diagnosed as metastatic spinal tumor due to cholangiocarcinoma. In a patient with AS, an acute aggravation of low back pain may be due to other pathologic conditions such as osteoporotic vertebral fracture, vertebral discitis and metastatic bone disease. Therefore, when a patient with AS presents with nonspecific low back pain, a physician should consider the above mentioned conditions.
증례 : 류마티스 ; Infliximab으로 치료한 건선 관절염 환자의 지염 1예
김담 ( Dam Kim ),손일웅 ( Il Woong Sohn ),김진주 ( Jin Ju Kim ),최윤영 ( Yun Young Choi ),정경희 ( Kyong Hee Jung ),김태환 ( Tae Hwan Kim ),성윤경 ( Yoon Kyoung Sung ) 대한내과학회 2011 대한내과학회지 Vol.80 No.2S
저자들은 건선 관절염으로 NSAIDs를 사용하던 환자에서 양측 엄지손가락의 지간 관절 및 말단과 양측 발의 지간 관절을 대칭적으로 침범한 건선 관절염에 의한 지염을 관찰하였고, infliximab을 투여하여 치료한 예를 경험하여 이런 예가 국내에서 보고가 없었으므로 이를 보고한다. 또한 본 환자에서는 단순 방사선 사진에서의 변화가 뚜렷하지 않아 bone scan 중 blood pool image로의 추적관찰이 유용했다. Dactylitis is a hallmark feature of psoriatic arthritis. It is usually managed with non-steroidal anti-inflammatory drugs and oral corticosteroids. Some cases have been treated successfully with intravenous corticosteroids or some disease-modifying antirheumatic drugs. Recently, inflximab has been reported as an effective treatment for dactylitis that is resistant to conventional treatment. This report describes a 37-year-old man with psoriatic arthritis who had multiple dactylitis on both thumbs and great toes. He was resistant to conventional treatment but was effectively treated with infliximab. This report highlights the effectiveness of infliximab for dactylitis, and the usefulness of blood pool imaging from bone scans as a method for determining treatment response. (Korean J Med 2011;80:S310-S313)
피부근육염/다발근육염에서 발생한 자발 종격동기종의 임상적 의미
김진주 ( Jin Ju Kim ),김담 ( Dam KIm ),김은경 ( Eun Kyoung Kim ),손일웅 ( Il Woong Sohn ),정경희 ( Kyong Hee Jung ),최찬범 ( Chan Bum Choi ),성윤경 ( Yoon Kyoung Sung ),전재범 ( Jae Bum Jun ),엄완식 ( Wan Sik Uhm ),김태환 ( Tae H 대한류마티스학회 2010 대한류마티스학회지 Vol.17 No.2
Objective: Pneumomediastinum (PnM), a rare complication of dermatomyositis and polymyositis (DM/PM), is sporadic and has an unclear pathogenesis. PnM is almost always associated with interstitial lung disease (ILD), and is a poor prognostic factor in inflammatory myositis patients. We studied the prevalence of PnM in Korean DM/PM and its clinical significance. Methods: We retrospectively studied the medical records of 161 patients diagnosed with DM/PM meeting Bohan-Peter`s criteria at Hanyang University Hospital for Rheumatic Diseases from 1995 to 2010. We collected following findings; demographic data, diagnosis, lung involvement, cause of death, and duration from diagnosis to death. Results: One hundred nineteen patients (73.9%) were DM and 42 patients (26.1%) were PM. Eighty three patients (51.6%) developed ILD at diagnosis or during follow up. Eighteen patients (11.2%) died because of ILD aggravation, infection, or malignancy. The mean duration from diagnosis to death was 11.5 months, with 10 patients (6.2%) dying from from ILD aggravation but none with spontaneous PnM. 6 patients (3.7%) presented with PnM, and it was associated with ILD worsening in all cases. PnM resolved with O2 inhalation, corticosteroids, and/or immunosuppressive agents after 11 weeks (mean) of therapy Conclusion: PnM is rare but associates with DM and aggravation of ILD. PnM does not usually cause fatalities and can be cured by appropriate therapy.